Status:
UNKNOWN
Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Infertility
Eligibility:
FEMALE
40-45 years
Phase:
NA
Brief Summary
In an era of delayed fertility plans, there is increasing need for fertility treatment in older women with poor response. Human chorionic gonadotropin (hCG) supplementation prior to treatment, as a th...
Eligibility Criteria
Inclusion
- women \>39 years on IVF treatment
Exclusion
- polycystic ovary syndrome
- Any allergy to injection of human chorionic gonadotropin before
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01205009
Start Date
April 1 2011
Last Update
March 2 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Center
Jerusalem, Israel, Israel